UnknownNot Applicable

Surgicel® (Fibrillar) in Non-variceal UGI Bleeding

South Korea

Plain-language summary

The aim of this study is to assess of effect of Surgicel® (Fibrillar) for preventing delayed bleeding after endoscopic hemostasis in non-variceal upper gastrointestinal bleeding

Who can participate

Age range20 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with non variceal upper gastrointestinal bleeding proven by esophagogastroduodenoscopy * Patients with active bleeding (Forrest classification Ia or Ib or IIa) Exclusion Criteria: * Patients with upper gastrointestinal tract malignancy * Patients with acute severe illness * Coagulopathy: liver cirrhosis, thrombocytopenia * Pregnant women

What they're measuring

Rebleeding rate at the second look endoscopy

Timeframe: 2 year

Trial details

NCT IDNCT02054260

SponsorSoonchunhyang University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-12

Contact for this trial

Su Jin Hong, MD, PhD

+82-32-621-5087 sjhong@schmc.ac.kr

View on ClinicalTrials.gov More Non-variceal Upper Gastrointestinal Bleeding trials